NCT07136545: A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)

Sponsor: Taipei Veterans General Hospital, Taiwan. Phase: PHASE1. Conditions: HNSCC